Clinical Trial Update: Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olaparib with paclitaxel versus paclitaxel alone in gastric cancer has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Olaparib (Olaparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-04-30